New Breast Cancer TreatmentProvides information on the MammoSite Radiation Therapy System for breast cancer.Medical Update
It is the first time any drug has been approved to treat certain patients with metastatic breast cancer who have a "BRCA" gene mutation, the FDA said on Friday. Patients are selected for treatment with Lynparza based on an FDA-approved genetic test. "This class of drugs has been used to...
About a third of breast cancer survivors are still living with fatigue and reduced exercise capacity after treatment ends. The field of breast cancer research is rapidly evolving, with more efficacious treatment options than ever before. However, many survivors are still facing long-term adverse ...
New treatments for breast cancer: Breakthroughs for patient care or just steps in the right direction? Three areas of clinical research in breast cancer treatment led to news breaking presentations at the American Society of Clinical Oncology (ASCO) meeting,... A Goldhirsch,AS Coates,M Castiglione...
The study could lead to new treatment strategies for patients with triple-negative breast cancer, including targeting NAC1 to kill the root of cancer, and restore the immune system's ability to recognize and fight cancer cells. This study's findings are particularly significant becausetriple-negativ...
Both immunotherapies and targeted therapies are showing significant promise in these areas, offering patients new treatment options.Q: The sub-category of HER2-low has been a major recent development in breast cancer. Why is this category and its identification so important? Danielle Roman, PharmD,...
Approximately 10 to 15 percent of breast cancer cases do not respond to treatment with hormone therapy, which means that they are more aggressive and often recur. An international research team led by researchers at Lund University in Sweden has uncovere
Tracy Hampton, PhD JAMA.2015;313(12):1199. doi:10.1001/jama.2015.2195 FullText The US Food and Drug Administration (FDA) has granted accelerated approval for the cyclin-dependent kinase (4/6) inhibitor palbociclib, or Ibrance, to be used in combination with letrozole for the treatment of post...
When cancer is detected early, patients live longer, require less extensive treatment, and in general fare better than patients with more advanced disease... DAC Jotwani,JR Gralow - 《Molecular Diagnosis & Therapy》 被引量: 9发表: 2009年 Endoxifen shows promise in breast cancer In a phase I...
The scientists are now testing the efficacy of their combination therapy in pre-clinical animal models with a view to future testing in clinical trials for breast cancer treatment. Read the full storyhere. Read the publication in Molecular Cell titled:Control of Glucocorticoid Receptor Levels by PTE...